Julie R Smith, True Nature, Mitesco

True Nature|Mitesco President & COO, Julie Smith Interview.

Julie R. Smith is a seasoned senior executive and board member with more than 25 years of success spanning healthcare, technology, education and retail....

True Nature|Mitesco (TNTY). Coverage Report Issued.

Record Volume and Gradually Rising Price Portends to Higher Prices in 2020 as True Nature Executes on Recently Announced Incubator Strategy. The big picture concept at...
steven boyd, biotech stock review

Armistice Capital Master Fund Ltd., and Citius Pharma (CTXR).

April 2019 Offering On April 1, 2019, Citius entered into securities purchase agreements with institutional investors and accredited investors for the sale by us of...

Bellus Health (BLUSF) to Present at SF Stock & Bond Club.

Presenter: Roberto Bellini - President and Chief Executive Officer See you there, 5:30 tonight. Roberto Bellini has served as President and CEO of BELLUS Health since...
Biotech Stock Review,

Premier Health (PHGRF) Announces Definitive Agreement to Acquire Livecare.

Livecare is an established leader in the Canadian digital health spaceHave provided over 27,000 telemedicine visitsService over 500 independent active health practitioner accounts, some...
biotech stock review

7 Million Telehealth Users This Year, Expected to Drive Revenues to $36 Billion in...

As boomers age, experts predict the telehealth market will grow from a $14.3 billion industry in 2013 to a $36.2 billion industry in 2020....

Is Telemedicine For Real?

Can physicians and nurses provide quality care through a computer connection? (AARP) Mercy Virtual has been called a hospital without patients, and the description is...

Mass General Brigham to Invest $100 Million in Telehealth and Digital Tools.

The five-year project aims to support consumer-centered care and patient engagement technology use. PatientEngagementHIT.com "Project leaders will focus on making healthcare more convenient and accessible to...
Biotech Stock Review, Dyve Pharma

Dyve Biosciences (Private) Receives FDA Clearance to Begin Phase 2 Study of DYV-700 for...

THOUSAND OAKS, Ca.--(BUSINESS WIRE)--Dyve Biosciences, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration to proceed with a...
biogen, biotech stock review

“I Dare the FDA not to Approve Our Drug.”

"Woe, Woe, Woe Wait a Minute. We Meant That Biogen Respects and Appreciates the FDA Review Process.” All Hail the FDA! Biogen (BIIB). Biogen’s top...

Latest article

Party Time at UniQure (QURE)! From $8.86 to $47.21, up 432%.

I. No Bells, No Baskets.UniQure (QURE) $47 up Huge. Still Not Out Of The Woods!II.Replimune (REPL) $11.23. Gains 28% in Sympathy with UniQure. We...

Adding Bavarian Nordic (BVRNY) $8.91, to Watch List.

Bavarian Nordic Lands $106 Million Contract for its Smallpox/Mpox Vaccine! Were Back for the Third Time! LIVE QUOTE PREVIOUS WRITEUPS Aug 27, 2025: Our 4th Billion Dollar Takeover!...

Fusion Energy Starter.

VC-Funded Fusion Energy Companies "The fastest way to deploy fusion and I believe one of my forecasts is we will replace every coal and natural...